Phenylbutyrate is a Multifaceted Drug that Exerts Neuroprotective Effects and Reverses the Alzheimer´s Disease-like Phenotype of a Commonly Used Mouse Model

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|28|5076-5084

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.28, 2013-04, pp. : 5076-5084

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer’s disease

By Easton Amy   Sankaranarayanan Sethu   Tanghe An   Terwel Dick   Lin Alan   Hoque Nina   Bourin Clotilde   Gu Huidong   Ahlijanian Michael   Bristow Linda  

Psychopharmacology, Vol. 230, Iss. 2, 2013-11 ,pp. : 279-289

Springer Publishing Company

Access to resources Recommend Favorite

Alzheimer’s disease: transgenic mouse models and drug assessment

By Yu P.   Oberto G.  

Pharmacological Research, Vol. 42, Iss. 2, 2000-08 ,pp. : 107-114

Academic Press

Access to resources Recommend Favorite

Chronic Stress and Alzheimer's Disease-Like Pathogenesis in a Rat Model: Prevention by Nicotine

By  

Current Neuropharmacology, Vol. 9, Iss. 4, 2011-12 ,pp. : 587-597

Bentham Science Publishers

Access to resources Recommend Favorite

Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer’s disease

By Van Dam Debby   Coen Katrien   De Deyn Peter  

Psychopharmacology, Vol. 197, Iss. 1, 2008-03 ,pp. : 37-43

Springer Publishing Company

Access to resources Recommend Favorite

The presenilins as potential drug targets in Alzheimer’s disease

By Cupers P.   Annaert W.G.   Strooper B.D.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 3, 1999-09 ,pp. : 413-422

Informa Healthcare

Access to resources Recommend Favorite